SPOTLIGHT: GSK buys Reliant Pharma for $1.65B

Breaking news: GlaxoSmithKline will pay $1.65 billion to buy U.S.-based Reliant Pharmaceuticals, a privately held drug maker that specializes in cardiovascular remedies. Reliant recently posted 9-month revenues of $341 million. Release | Report